Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

1,313 total articles

International Seaways CEO Disposes of $127,919 in Stock; Company Sells Older Vessels as Tanker Rates Climb

International Seaways CEO Disposes of $127,919 in Stock; Company Sells Older Vessels as Tanker Rates Climb

International Seaways President and CEO Lois K. Zabrocky sold 2,000 shares of company stock on February 17, 2026, under a Rule 10b5-1 plan, generating proceeds of $127,919. The company also disclosed the sale or agreements to sell five older vessels for about $185 million net. Market commentary from BTIG shows increased price targets for peers amid…

Day One Biopharma CCO Sells $67K in Stock After Exercising RSUs; Company Posts Strong OJEMDA Revenue Growth

Day One Biopharma CCO Sells $67K in Stock After Exercising RSUs; Company Posts Strong OJEMDA Revenue Growth

Day One Biopharmaceuticals reported an insider sale by Chief Commercial Officer Lauren Merendino on February 17, 2026, totaling 5,814 shares for about $67,447. Two days earlier she exercised 15,162 restricted stock units. The company disclosed preliminary 2025 net product revenue for OJEMDA of $155.4 million, issued 2026 U.S. net product revenue gu…

RBC Bearings Vice President Disposes of $2.27M in Shares; Exercises Options Amid Strong Q3 2025 Results

RBC Bearings Vice President Disposes of $2.27M in Shares; Exercises Options Amid Strong Q3 2025 Results

RBC Bearings V.P. and General Manager Richard J. Edwards sold 4,100 shares on February 17, 2026, realizing $2,270,519, and exercised options to buy 2,600 shares for $555,384 the same day. After the transactions he directly holds 11,084 shares. The moves occurred shortly after the company reported stronger-than-expected Q3 2025 results and received …

Vir Biotechnology SVP Executes Rule 10b5-1 Sale; Company Posts Strong Phase 2 Hepatitis Delta Data and Strikes Norgine Deal

Vir Biotechnology SVP Executes Rule 10b5-1 Sale; Company Posts Strong Phase 2 Hepatitis Delta Data and Strikes Norgine Deal

Brent Sabatini, SVP and Chief Accounting Officer at Vir Biotechnology (VIR), completed an automatic sale of 1,530 shares on February 13, 2026, under a pre-arranged Rule 10b5-1 plan to satisfy tax withholding tied to restricted stock unit vesting. The transaction totaled $11,918 at $7.79 per share, leaving Sabatini with 47,872 shares. Separately, Vi…

Caterpillar Accounting Chief Disposes of 972 Shares Worth $742,802 as Company Posts Strong Q4 2025 Results

Caterpillar Accounting Chief Disposes of 972 Shares Worth $742,802 as Company Posts Strong Q4 2025 Results

William E. Schaupp, Caterpillar's Chief Accounting Officer, sold 972 shares of the company on February 17, 2026, in a transaction valued at $742,802. The sale, reported on a Form 4 filed with the Securities and Exchange Commission, left Schaupp with 824 shares. Separately, Caterpillar posted fourth-quarter 2025 results that exceeded expectations, r…

EZCORP Legal Chief Disposes $500,000 in Stock; Firm Posts Strong Quarter and Expands Store Footprint

EZCORP Legal Chief Disposes $500,000 in Stock; Firm Posts Strong Quarter and Expands Store Footprint

Ellen H. Bryant, Chief Legal Officer of EZCORP INC, sold 20,000 shares of Class A non-voting common stock on February 17, 2026, realizing $500,000 at $25.00 a share. The transaction leaves Bryant with 147,786 shares. Separately, EZCORP posted a strong fiscal first quarter with adjusted EBITDA of $70 million, attributed in part to higher gold prices…